Skip to main content

Table 1 Triple negative cell lines used in the studies based on their p53 and BRCA1 mutation status

From: Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

Cell line

BRCA1 status1

P53 status2

MDA-MB-453

WT

367 30 bp deletion

MDA-MB-231

WT

280 Arg - > Lys

HCC1937

5382insC (fs > 1829X)

306 Arg - > stop